{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:40:59Z","timestamp":1776307259098,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10633-025-10076-5","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T02:27:08Z","timestamp":1767752828000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retinal electrophysiological responses to dopaminergic therapy in treatment na\u00efve Parkinson\u2019s disease"],"prefix":"10.1007","volume":"152","author":[{"given":"Merve","family":"Ergun Yildiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidayet","family":"Sener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice Kubra","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman Ahmet","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Horozoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"10076_CR1","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"issue":"10291","key":"10076_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"11","key":"10076_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"SK Van Den Eeden","year":"2003","unstructured":"Van Den Eeden SK, Tanner CM, Bernstein AL et al (2003) Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity. Am J Epidemiol 157(11):1015\u20131022. https:\/\/doi.org\/10.1093\/aje\/kwg068","journal-title":"Am J Epidemiol"},{"key":"10076_CR4","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"issue":"7","key":"10076_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10076_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318(1):121\u2013134. https:\/\/doi.org\/10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"issue":"12","key":"10076_CR7","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE et al (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8(12):1150\u20131157. https:\/\/doi.org\/10.1016\/S1474-4422(09)70238-8","journal-title":"Lancet Neurol"},{"issue":"7","key":"10076_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12264-021-00711-x","volume":"37","author":"Y Liu","year":"2021","unstructured":"Liu Y, Niu L, Liu X, Cheng C, Le W (2021) Recent progress in non-motor features of Parkinson\u2019s disease with a focus on circadian rhythm dysregulation. Neurosci Bull 37(7):1010\u20131024. https:\/\/doi.org\/10.1007\/s12264-021-00711-x","journal-title":"Neurosci Bull"},{"issue":"4","key":"10076_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00221-013-3621-2","volume":"230","author":"P Huot","year":"2013","unstructured":"Huot P, Fox SH (2013) The serotonergic system in motor and non-motor manifestations of Parkinson\u2019s disease. Exp Brain Res 230(4):463\u2013476. https:\/\/doi.org\/10.1007\/s00221-013-3621-2","journal-title":"Exp Brain Res"},{"issue":"10","key":"10076_CR10","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2174\/011570159X368923250313045859","volume":"23","author":"SY Tian","year":"2025","unstructured":"Tian SY, Cao X, Liu GJ et al (2025) Role of the central cholinergic nervous system in motor and non-motor symptoms of Parkinson\u2019s disease. Curr Neuropharmacol 23(10):1232\u20131248. https:\/\/doi.org\/10.2174\/011570159X368923250313045859","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"10076_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.smrv.2010.06.001","volume":"15","author":"C Schmoll","year":"2011","unstructured":"Schmoll C, Lascaratos G, Dhillon B, Skene D, Riha RL (2011) The role of retinal regulation of sleep in health and disease. Sleep Med Rev 15(2):107\u2013113. https:\/\/doi.org\/10.1016\/j.smrv.2010.06.001","journal-title":"Sleep Med Rev"},{"issue":"2","key":"10076_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.visres.2010.07.023","volume":"51","author":"C La Morgia","year":"2011","unstructured":"La Morgia C, Ross-Cisneros FN, Hannibal J, Montagna P, Sadun AA, Carelli V (2011) Melanopsin-expressing retinal ganglion cells: implications for human diseases. Vision Res 51(2):296\u2013302. https:\/\/doi.org\/10.1016\/j.visres.2010.07.023","journal-title":"Vision Res"},{"issue":"2","key":"10076_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10633-023-09945-8","volume":"147","author":"OA Polat","year":"2023","unstructured":"Polat OA, Gultekin M, Sener H, Ozer F, Arda H (2023) Retinal dysfunction in Parkinson\u2019s disease-results of the extended protocol for photopic negative response (PHNR) full-field electroretinogram (ERG). Doc Ophthalmol 147(2):89\u201398. https:\/\/doi.org\/10.1007\/s10633-023-09945-8","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10076_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10072-018-3244-2","volume":"39","author":"M Unlu","year":"2018","unstructured":"Unlu M, Gulmez Sevim D, Gultekin M, Karaca C (2018) Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson\u2019s disease. Neurol Sci 39(3):533\u2013541. https:\/\/doi.org\/10.1007\/s10072-018-3244-2","journal-title":"Neurol Sci"},{"issue":"5","key":"10076_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awp068","volume":"132","author":"NK Archibald","year":"2009","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson\u2019s disease. Brain 132(5):1128\u20131145. https:\/\/doi.org\/10.1093\/brain\/awp068","journal-title":"Brain"},{"key":"10076_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.04.023","volume":"64","author":"A Chrysou","year":"2019","unstructured":"Chrysou A, Jansonius NM, van Laar T (2019) Retinal layers in Parkinson\u2019s disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord 64:40\u201349. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.04.023","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10076_CR17","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.3390\/cells10123269","volume":"10","author":"M Ptito","year":"2021","unstructured":"Ptito M, Bleau M, Bouskila J (2021) The retina: a window into the brain. Cells 10(12):3269. https:\/\/doi.org\/10.3390\/cells10123269","journal-title":"Cells"},{"issue":"7526","key":"10076_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nj7526-299a","volume":"515","author":"K Gammon","year":"2014","unstructured":"Gammon K (2014) Neurodegenerative disease: brain windfall. Nature 515(7526):299\u2013300. https:\/\/doi.org\/10.1038\/nj7526-299a","journal-title":"Nature"},{"key":"10076_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.parkreldis.2022.06.018","volume":"101","author":"LGM Mello","year":"2022","unstructured":"Mello LGM, Paraguay IBB, Andrade TS et al (2022) Electroretinography reveals retinal dysfunction in Parkinson\u2019s disease despite normal high-resolution optical coherence tomography findings. Parkinsonism Relat Disord 101:90\u201395. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.06.018","journal-title":"Parkinsonism Relat Disord"},{"key":"10076_CR20","doi-asserted-by":"publisher","DOI":"10.3233\/jpd-191830","author":"R Netser","year":"2020","unstructured":"Netser R, Demmin D, Dobkin R et al (2020) Flash Electroretinography Parameters and Parkinson\u2019s Disease. J Parkinson\u2019s Disease. https:\/\/doi.org\/10.3233\/jpd-191830","journal-title":"J Parkinson\u2019s Disease."},{"issue":"1","key":"10076_CR21","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","volume":"22","author":"A Sauerbier","year":"2016","unstructured":"Sauerbier A, Jenner P, Todorova A, Chaudhuri KR (2016) Non motor subtypes and Parkinson\u2019s disease. Parkinsonism Relat Disord 22(1):S41\u2013S46. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.027","journal-title":"Parkinsonism Relat Disord"},{"key":"10076_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fnagi.2017.00301","volume":"9","author":"J Mu","year":"2017","unstructured":"Mu J, Chaudhuri KR, Bielza C, de Pedro-Cuesta J, Larra\u00f1aga P, Martinez-Martin P (2017) Parkinson\u2019s disease subtypes identified from cluster analysis of motor and non-motor symptoms. Front Aging Neurosci 9:301. https:\/\/doi.org\/10.3389\/fnagi.2017.00301","journal-title":"Front Aging Neurosci"},{"issue":"23","key":"10076_CR23","doi-asserted-by":"publisher","first-page":"7434","DOI":"10.3390\/jcm12237434","volume":"12","author":"T Petrijan","year":"2023","unstructured":"Petrijan T, Zmazek J, Menih M (2023) Parkinson\u2019s Disease Non-Motor Subtypes Classification in a group of Slovenian patients: actuarial vs. data-driven approach. J Clin Med 12(23):7434. https:\/\/doi.org\/10.3390\/jcm12237434","journal-title":"J Clin Med"},{"key":"10076_CR24","doi-asserted-by":"publisher","first-page":"107982","DOI":"10.1016\/j.parkreldis.2025.107982","volume":"140","author":"V Velucci","year":"2025","unstructured":"Velucci V, Iliceto G, Vitucci B et al (2025) Non-motor symptom subtypes in early Parkinson\u2019s disease. Parkinsonism Relat Disord 140:107982. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107982","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10076_CR25","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"9","key":"10076_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz CG, Poewe W, Rascol O et al (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19(9):1020\u20131028. https:\/\/doi.org\/10.1002\/mds.20213","journal-title":"Mov Disord"},{"issue":"3","key":"10076_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10633-018-9638-x","volume":"136","author":"L Frishman","year":"2018","unstructured":"Frishman L, Sustar M, Kremers J et al (2018) ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc Ophthalmol 136(3):207\u2013211. https:\/\/doi.org\/10.1007\/s10633-018-9638-x","journal-title":"Doc Ophthalmol"},{"issue":"19","key":"10076_CR28","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/0042-6989(94)90248-8","volume":"34","author":"H Ikeda","year":"1994","unstructured":"Ikeda H, Head GM, Ellis CJ (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson\u2019s disease and a follow up study. Vision Res 34(19):2629\u20132638. https:\/\/doi.org\/10.1016\/0042-6989(94)90248-8","journal-title":"Vision Res"},{"issue":"6","key":"10076_CR29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1212\/wnl.45.6.1144","volume":"45","author":"A Peppe","year":"1995","unstructured":"Peppe A, Stanzione P, Pierelli F, De Angelis D, Pierantozzi M, Bernardi G (1995) Visual alterations in de novo Parkinson\u2019s disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology 45(6):1144\u20131148. https:\/\/doi.org\/10.1212\/wnl.45.6.1144","journal-title":"Neurology"},{"issue":"12","key":"10076_CR30","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s10792-020-01515-0","volume":"40","author":"M Prencipe","year":"2020","unstructured":"Prencipe M, Perossini T, Brancoli G, Perossini M (2020) The photopic negative response (PhNR): measurement approaches and utility in glaucoma. Int Ophthalmol 40(12):3565\u20133576. https:\/\/doi.org\/10.1007\/s10792-020-01515-0","journal-title":"Int Ophthalmol"},{"issue":"5","key":"10076_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00004691-200309000-00010","volume":"20","author":"F Sartucci","year":"2003","unstructured":"Sartucci F, Orlandi G, Lucetti C et al (2003) Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson\u2019s disease. J Clin Neurophysiol 20(5):375\u2013381. https:\/\/doi.org\/10.1097\/00004691-200309000-00010","journal-title":"J Clin Neurophysiol"},{"issue":"28","key":"10076_CR32","doi-asserted-by":"publisher","first-page":"30397","DOI":"10.1021\/acsomega.5c02063","volume":"10","author":"S Rao","year":"2025","unstructured":"Rao S, Xiao K, Chen X, Sun X (2025) Dopamine alleviated diabetic retinal neurodegeneration through protecting retinal ganglion cells from ferroptosis via the Nrf2\/HO-1 signaling pathway. ACS Omega 10(28):30397\u201330410. https:\/\/doi.org\/10.1021\/acsomega.5c02063","journal-title":"ACS Omega"},{"issue":"7","key":"10076_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1113\/JP284215","volume":"601","author":"RA Warwick","year":"2023","unstructured":"Warwick RA, Heukamp AS, Riccitelli S, Rivlin-Etzion M (2023) Dopamine differentially affects retinal circuits to shape the retinal code. J Physiol 601(7):1265\u20131286. https:\/\/doi.org\/10.1113\/JP284215","journal-title":"J Physiol"},{"issue":"7","key":"10076_CR34","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/jnnp.50.7.847","volume":"50","author":"MJ Jaffe","year":"1987","unstructured":"Jaffe MJ, Bruno G, Campbell G, Lavine RA, Karson CN, Weinberger DR (1987) Ganzfeld electroretinographic findings in parkinsonism: untreated patients and the effect of levodopa intravenous infusion. J Neurol Neurosurg Psychiatry 50(7):847\u2013852. https:\/\/doi.org\/10.1136\/jnnp.50.7.847","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10076_CR35","doi-asserted-by":"publisher","first-page":"106872","DOI":"10.1016\/j.nbd.2025.106872","volume":"208","author":"V Soto Linan","year":"2025","unstructured":"Soto Linan V, Rioux V, Peralta M 3rd, Dupr\u00e9 N, H\u00e9bert M, L\u00e9vesque M (2025) Early detection of Parkinson\u2019s disease: retinal functional impairments as potential biomarkers. Neurobiol Dis 208:106872. https:\/\/doi.org\/10.1016\/j.nbd.2025.106872","journal-title":"Neurobiol Dis"},{"issue":"11","key":"10076_CR36","first-page":"2473","volume":"31","author":"C Harnois","year":"1990","unstructured":"Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson\u2019s disease. Invest Ophthalmol Vis Sci 31(11):2473\u20132475","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10076_CR37","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/mds.28280","volume":"35","author":"LGM Mello","year":"2020","unstructured":"Mello LGM, Bissoli LB, Saraiva FP, Maia RPD, Monteiro MLR (2020) Retinal layers and choroid measurements in Parkinson\u2019s disease with or without pramipexole treatment. Mov Disord 35(12):2357\u20132359. https:\/\/doi.org\/10.1002\/mds.28280","journal-title":"Mov Disord"},{"key":"10076_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000265957","volume":"4","author":"F Hempel","year":"1972","unstructured":"Hempel F (1972) Modification of the rabbit electroretinogram by reserpine. Ophthalmic Res 4:65\u201375. https:\/\/doi.org\/10.1159\/000265957","journal-title":"Ophthalmic Res"},{"issue":"2","key":"10076_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10633-015-9503-0","volume":"131","author":"B Nowacka","year":"2015","unstructured":"Nowacka B, Lubi\u0144ski W, Honczarenko K, Potemkowski A, Safranow K (2015) Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson\u2019s disease (PD). Doc Ophthalmol 131(2):95\u2013104. https:\/\/doi.org\/10.1007\/s10633-015-9503-0","journal-title":"Doc Ophthalmol"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-025-10076-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-025-10076-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-025-10076-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:46:59Z","timestamp":1776304019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-025-10076-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10076"],"URL":"https:\/\/doi.org\/10.1007\/s10633-025-10076-5","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This prospective observational study was conducted in collaboration between the Departments of Ophthalmology and Neurology at Erciyes University, and was approved by the Non-Interventional Clinical Research Ethics Committee of Erciyes University (Approval No: 2025\/299). All procedures adhered to the principles of the Declaration of Helsinki and its later amendments. Written informed consent was obtained from all participants prior to inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and \u0131nformed consent"}}]}}